1.Comparison of two pharmacokinetic models to describe the double-peak absorption profiles of ranitidine.

Chow, MSS, Yin, QP,     More...

Chow, MSS, Yin, QP, Tomlinson, B, Chow, AHL     Less

CLINICAL PHARMACOLOGY & THERAPEUTICS[0009-9236], Published 2001, Volume 69, Issue 2, Pages P23-P23

收錄情况： WOS

WOS核心合集引用: 1  2023影響因子:  6.3  发表年影響因子:  5.061 

2.A "high-throughput" cocktail method for screening the effect of herbal product on liver isozyme activities: Experience with Ginkgo biloba.

Sun, H, Zuo, Z, Yin,     More...

Sun, H, Zuo, Z, Yin, OQ, Tomlinson, B, Chow, MS     Less

CLINICAL PHARMACOLOGY & THERAPEUTICS[0009-9236], Published 2002, Volume 71, Issue 2, Pages P100-P100

收錄情况： WOS

WOS核心合集引用: 5  2023影響因子:  6.3  发表年影響因子:  5.336 

3.Reliability of a single omeprazole/hydroxyomeprazole plasma concentration ratio for CYP2C19 phenotype determination in Chinese subjects.

Yin, OQ, Tomlinson,     More...

Yin, OQ, Tomlinson, B, Waye, MM, Chow, AH, Chow, MS     Less

CLINICAL PHARMACOLOGY & THERAPEUTICS[0009-9236], Published 2003, Volume 73, Issue 2, Pages P43-P43

收錄情况： WOS

WOS核心合集引用: 0  2023影響因子:  6.3  发表年影響因子:  6.141 

4.Prediction and mechanism of herb-drug interaction: Effect of ginkgo biloba on omeprazole in Chinese subjects.

Yin, OQ, Tomlinson,     More...

Yin, OQ, Tomlinson, B, Chow, MS     Less

CLINICAL PHARMACOLOGY & THERAPEUTICS[0009-9236], Published 2003, Volume 73, Issue 2, Pages P94-P94

收錄情况： WOS

WOS核心合集引用: 2  2023影響因子:  6.3  发表年影響因子:  6.141 

5.The effect of CYP2D6 genotype on the pharmacokinetics of lovastatin in Chinese subjects.

Yin, OQ, Chang, Q, T     More...

Yin, OQ, Chang, Q, Tomlinson, B, Chow, S     Less

CLINICAL PHARMACOLOGY & THERAPEUTICS[0009-9236], Published 2004, Volume 75, Issue 2, Pages P18-P18

收錄情况： WOS

WOS核心合集引用: 1  2023影響因子:  6.3  发表年影響因子:  6.825 

6.Effects of combined CYP2C9 and 2C19 polymorphism on the pharmacokinetics of glibenclamide in Chinese subjects.

Yin, OQ, Tomlinson,     More...

Yin, OQ, Tomlinson, B, Chow, MS     Less

CLINICAL PHARMACOLOGY & THERAPEUTICS[0009-9236], Published 2005, Volume 77, Issue 2, Pages P23-P23

收錄情况： WOS

WOS核心合集引用: 0  2023影響因子:  6.3  发表年影響因子:  7.526 

7.A five-probe drug cocktail for phenotyping of CYP isozymes with "high-throughput" LC-MS method.

Yin, OQ, Tomlinson,     More...

Yin, OQ, Tomlinson, B, Chow, MS     Less

CLINICAL PHARMACOLOGY & THERAPEUTICS[0009-9236], Published 2005, Volume 77, Issue 2, Pages P35-P35

收錄情况： WOS

WOS核心合集引用: 3  2023影響因子:  6.3  发表年影響因子:  7.526 

8.CYP2C9, but not CYP2C19, polymorphisms affect the pharmacokinetics and pharmacodynamics of glyburide in Chinese subjects

Yin, OQP, Tomlinson,     More...

Yin, OQP, Tomlinson, B, Chow, MSS     Less

CLINICAL PHARMACOLOGY & THERAPEUTICS[0009-9236], Published 2005, Volume 78, Issue 4, Pages 370-377

收錄情况： WOS SCOPUS

WOS核心合集引用: 52  2023影響因子:  6.3  发表年影響因子:  7.526 

9.No association between CYP3A5 genotype and blood pressure in healthy Chinese subjects.

Yin, QQ, Tomlinson,     More...

Yin, QQ, Tomlinson, B, Xie, C, Chow, MS     Less

CLINICAL PHARMACOLOGY & THERAPEUTICS[0009-9236], Published 2006, Volume 79, Issue 2, Pages P11-P11

收錄情况： WOS

WOS核心合集引用: 0  2023影響因子:  6.3  发表年影響因子:  8.066 

10.CYP3A5 but not CYP2D6 polymorphism affects dextropropoxyphene disposition in human subjects.

Chow, MS, Yin, OQ, T     More...

Chow, MS, Yin, OQ, Tomlinson, B     Less

CLINICAL PHARMACOLOGY & THERAPEUTICS[0009-9236], Published 2006, Volume 79, Issue 2, Pages P50-P50

收錄情况： WOS

WOS核心合集引用: 0  2023影響因子:  6.3  发表年影響因子:  8.066 

11.MDR1 haplotype dependent effect on cloxacillin pharmacokinetics in human subjects.

Yin, OQ, Tomlinson,     More...

Yin, OQ, Tomlinson, B, Wang, Z, Chow, MS     Less

CLINICAL PHARMACOLOGY & THERAPEUTICS[0009-9236], Published 2008, Volume 83, Pages S65-S66

收錄情况： WOS

WOS核心合集引用: 0  2023影響因子:  6.3  发表年影響因子:  7.586 

12.ABCG2 Polymorphism Is Associated With the Low-Density Lipoprotein Cholesterol Response to Rosuvastatin

Tomlinson, B, Hu, M,     More...

Tomlinson, B, Hu, M, Lee, VWY, Lui, SSH, Chu, TTW, Poon, EWM, Ko, GTC, Baum, L, Tam, LS, Li, EK     Less

CLINICAL PHARMACOLOGY & THERAPEUTICS[0009-9236], Published 2010, Volume 87, Issue 5, Pages 558-562

收錄情况： WOS SCOPUS

WOS核心合集引用: 114  2023影響因子:  6.3  发表年影響因子:  6.378 

13.Comparison of two pharmacokinetic models to describe the double-peak absorption profiles of ranitidine

Chow, Moses Sing Sum     More...

Chow, Moses Sing Sum, Yin, Q. P., Tomlinson, Brian, Chow, Albert H.L.     Less

Clinical Pharmacology and Therapeutics[0009-9236], Published 2001, Volume 69, Issue 2,

收錄情况： SCOPUS

2023影響因子:  6.3  发表年影響因子:  5.061 

14.CYP2C19 Loss-of-function Polymorphisms are Associated with Reduced Risk of Sulfonylurea Treatment Failure in Chinese Patients with Type 2 Diabetes

Wang, K, Yang, AM, S     More...

Wang, K, Yang, AM, Shi, M, Tam, CCH, Lau, ESH, Fan, BQ, Lim, CKP, Lee, HM, Kong, APS, Luk, AOY, Tomlinson, B, Ma, RCW, Chan, JCN, Chow, E     Less

CLINICAL PHARMACOLOGY & THERAPEUTICS[0009-9236], Published 2021, Volume 111, Issue 2, Pages 461-469

收錄情况： WOS SCOPUS

WOS核心合集引用: 5  2023影響因子:  6.3  发表年影響因子:  7.051